| Detected | Trial | Change |
|---|---|---|
| 2026-05-16 | NCT07154745 A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult… |
Trial sites expanded: 8 -> 11 locations |
| 2026-05-16 | NCT07154745 A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult… |
date change Primary completion pushed: 2029-11-07 -> 2030-01-06 |
| 2026-05-16 | NCT07154745 A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult… |
date change Completion pushed: 2031-09-23 -> 2031-11-22 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05744921 | A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How… | Paroxysmal Nocturnal Hemoglobinuria | Recruiting |
| NCT07154745 | A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult… | Paroxysmal Nocturnal Hemoglobinuria | Recruiting |
| NCT06541704 | A Study Investigating Subcutaneously Administered Pozelimab in Combination With… | Age-related Macular Degeneration (AMD) | Recruiting |
| NCT05070858 | A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran… | Generalized Myasthenia Gravis | Active, Not Recruiting |
| NCT05133531 | A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well… | Paroxysmal Nocturnal Hemoglobinuria | Active, Not Recruiting |